Referanslar

1. Kabalak AA, Yasti AC. Management of inhalation injury and respiratory complications in Burns Intensive Care Unit. Ulus Travma Acil Cerrahi Derg 2012; 18(4): 333-8. [Crossref]  [PubMed]
2. Herndon DN. Total burn care. Fifth edition. ed. Edinburgh: Elsevier; 2018. [Link]
3. Sheridan RL. Fire-Related Inhalation Injury. N Engl J Med 2016 375(19): 1905. [Crossref]  [PubMed]
4. Dries DJ, Endorf FW. Inhalation injury: epidemiology, pa- thology, treatment strategies. Scand J Trauma Resusc Emerg Med 2013; 21: 31. [Crossref]  [PubMed]  [PMC]
5. Foncerrada G, Culnan DM, Capek KD, et al. Inhalation Inju- ry in the Burned Patient. Ann Plast Surg 2018; 80 (3 Suppl 2): S98-S105. [Crossref]  [PubMed]  [PMC]
6. Smith DL, Cairns BA, Ramadan F, et al. Effect of inhalation injury, burn size, and age on mortality: a study of 1447 con- secutive burn patients. J Trauma 1994; 37(4): 655-9. [Crossref]  [PubMed]
7. Tan Chor Lip H, Tan JH, Thomas M, Imran FH, Azmah Tuan Mat TN. Survival analysis and mortality predictors of hos- pitalized severe burn victims in a Malaysian burns intensive care unit. Burns Trauma 2019; 7: 3. [Crossref]  [PubMed]  [PMC]
8. Suzuki M, Aikawa N, Kobayashi K, Higuchi R. Prognos- tic implications of inhalation injury in burn patients in To- kyo. Burns 2005; 31(3): 331-6. [Crossref]  [PubMed]
9. Colohan SM. Predicting prognosis in thermal burns with as- sociated inhalational injury: a systematic review of prognos- tic factors in adult burn victims. J Burn Care Res 2010; 31(4): 529-39. [Crossref]  [PubMed]
10. Shirani KZ, Pruitt BA, Jr., Mason AD, Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987; 205(1): 82-7. [Crossref]  [PubMed]  [PMC]
11. Demling RH. Smoke inhalation lung injury: an update. Eplas- ty 2008; 8: e27. [PubMed]
12. Monteiro D, Silva I, Egipto P, et al. Inhalation injury in a burn unit: a retrospective review of prognostic factors. Ann Burns Fire Disasters 2017; 30(2): 121-5. [PubMed]
13. Woodson LC. Diagnosis and grading of inhalation injury. J Burn Care Res 2009; 30(1): 143-5. [Crossref]  [PubMed]
14. Rong YH, Liu W, Wang C, Ning FG, Zhang GA. Tempera- ture distribution in the upper airway after inhalation inju- ry. Burns 2011; 37(7): 1187-91. [Crossref]  [PubMed]
15. Rehberg S, Maybauer MO, Enkhbaatar P, Maybauer DM, Yamamoto Y, Traber DL. Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med 2009; 3(3): 283-97. [Crossref]  [PubMed]  [PMC]
16. Enkhbaatar P, Pruitt BA, Jr., Suman O, et al. Pathophysiolo- gy, research challenges, and clinical management of smoke inhalation injury. Lancet 2016; 388(10052): 1437-46. [Crossref]  [PubMed]
17. Miller K, Chang A. Acute inhalation injury. Emerg Med Clin North Am 2003; 21(2): 533-57. [Crossref]  [PubMed]
18. Friedl HP, Till GO, Trentz O, Ward PA. Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am J Pathol 1989; 135(1): 203-17. [PubMed]
19. Maybauer MO, Maybauer DM, Herndon DN, Traber DL. The role of superoxide dismutase in systemic inflamma- tion. Shock 2006; 25(2): 206-7. [Crossref]
20. Perez Fontan JJ. On lung nerves and neurogen- ic injury. Ann Med 2002; 34(4): 226-40. [Crossref]  [PubMed]
21. Sousse LE, Herndon DN, Andersen CR, et al. High tidal vol- ume decreases adult respiratory distress syndrome, atelecta- sis, and ventilator days compared with low tidal volume in pediatric burned patients with inhalation injury. J Am Coll Surg 2015; 220(4): 570-8. [Crossref]  [PubMed]  [PMC]
22. Sheridan RL. Recognition and management of hot liquid aspiration in children. Ann Emerg Med 1996; 27(1): 89-91. [Crossref]  [PubMed]
23. Rosen D, Avishai-Eliner S, Borenstein A, Leviav A, Tabach- nik E. Life-threatening laryngeal burns in toddlers following hot liquid aspiration. Acta Paediatr 2000; 89(8): 1018-20. [Crossref]  [PubMed]
24. Hassan Z, Wong JK, Bush J, Bayat A, Dunn KW. Assess- ing the severity of inhalation injuries in adults. Burns 2010; 36(2): 212-6. [Crossref]  [PubMed]
25. Albright JM, Davis CS, Bird MD, et al. The acute pulmonary inflammatory response to the graded severity of smoke in- halation injury. Crit Care Med 2012; 40(4): 1113-21. [Crossref]  [PubMed]  [PMC]
26. Lange M, Hamahata A, Traber DL, et al. Preclinical eval- uation of epinephrine nebulization to reduce airway hyper- emia and improve oxygenation after smoke inhalation injury. Crit Care Med 2011; 39(4): 718-24. [Crossref]  [PubMed]  [PMC]
27. Tuncer HB, Akin M, Cakirca M, Erkilic E, Yildiz HF, Yas- ti AC. Do pre-burn center management algorithms work? Evaluation of pre-admission diagnosis and treatment ade-quacy of burn patients referred to a burn center. J Burn Care Res 2024; 45(1): 180-9. [Crossref]  [PubMed]
28. Badulak JH, Schurr M, Sauaia A, Ivashchenko A, Peltz E. Defining the criteria for intubation of the patient with thermal burns. Burns 2018; 44(3): 531-8. [Crossref]  [PubMed]
29. Mlcak RP, Suman OE, Herndon DN. Respiratory manage- ment of inhalation injury. Burns 2007; 33(1): 2-13. [Crossref]  [PubMed]
30. McCall JE, Cahill TJ. Respiratory care of the burn patient. J Burn Care Rehabil 2005; 26(3): 200-6. [PubMed]
31. Palmieri TL, Enkhbaatar P, Bayliss R, et al. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med 2006; 34(6): 1719-24. [Crossref]
32. Jonkam C, Zhu Y, Jacob S, et al. Muscarinic receptor an- tagonist therapy improves acute pulmonary dysfunction af- ter smoke inhalation injury in sheep. Crit Care Med 2010; 38(12): 2339-44. [Crossref]  [PubMed]
33. Walker PF, Buehner MF, Wood LA, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care 2015; 19: 351. [Crossref]  [PubMed]  [PMC]
34. Villegas L, Stidham T, Nozik-Grayck E. Oxidative Stress and Therapeutic Development in Lung Diseases. J Pulm Respir Med 2014; 4(4). [Crossref]  [PubMed]  [PMC]
35. Elsharnouby NM, Eid HE, Abou Elezz NF, Aboelatta YA. Heparin/N-acetylcysteine: an adjuvant in the manage- ment of burn inhalation injury: a study of different doses. J Crit Care 2014; 29(1): 182 e1-4. [Crossref]  [PubMed]
36. Enkhbaatar P, Esechie A, Wang J, et al. Combined antico- agulants ameliorate acute lung injury in sheep after burn and smoke inhalation. Clin Sci (Lond) 2008; 114(4): 321-9. [Crossref]  [PubMed]
37. Desai MH, Mlcak R, Richardson J, Nichols R, Herndon DN. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy. J Burn Care Rehabil 1998; 19(3): 210-2. [Crossref]  [PubMed]
38. Glas GJ, Serpa Neto A, Horn J, et al. Nebulized heparin for patients under mechanical ventilation: an individual pa- tient data meta-analysis. Ann Intensive Care 2016; 6(1): 33. [Crossref]  [PubMed]  [PMC]
39. Kashefi NS, Nathan JI, Dissanaike S. Does a Nebulized Hep- arin/N-acetylcysteine Protocol Improve Outcomes in Adult Smoke Inhalation? Plast Reconstr Surg Glob Open 2014; 2(6): e165. [Crossref]  [PubMed]  [PMC]
40. McIntire AM, Harris SA, Whitten JA, et al. Outcomes Fol- lowing the Use of Nebulized Heparin for Inhalation Injury (HIHI Study). J Burn Care Res 2017; 38(1): 45-52. [Crossref]  [PubMed]
41. Ak AK, Cascella M. Post-Intubation Laryngeal Edema. Stat- Pearls. Treasure Island (FL); 2024. [PubMed]
42. Thompson JT, Molnar JA, Hines MH, Chang MC, Pran- ikoff T. Successful management of adult smoke inhalation with extracorporeal membrane oxygenation. J Burn Care Rehabil 2005; 26(1): 62-6. [Crossref]
43. Hale DF, Cannon JW, Batchinsky AI, et al. Prone position- ing improves oxygenation in adult burn patients with se- vere acute respiratory distress syndrome. J Trauma Acute Care Surg 2012; 72(6): 1634-9. [Crossref]  [PubMed]
44. Miller AC, Ferrada PA, Kadri SS, Nataraj-Bhandari K, Vahedian-Azimi A, Quraishi SA. High-Frequency Venti- lation Modalities as Salvage Therapy for Smoke Inhala- tion-Associated Acute Lung Injury: A Systematic Review. J Intensive Care Med 2018; 33(6): 335-45. [Crossref]  [PubMed]
45. Lucangelo U, Fontanesi L, Antonaglia V, et al. High fre- quency percussive ventilation (HFPV). Principles and tech- nique. Minerva Anestesiol 2003; 69(11): 841-8, 8-51. [PubMed]
46. Reper P, Wibaux O, Van Laeke P, Vandeenen D, Duinslae- ger L, Vanderkelen A. High frequency percussive ventila- tion and conventional ventilation after smoke inhalation: a randomised study. Burns 2002; 28(5): 503-8. [Crossref]  [PubMed]
47. Cortiella J, Mlcak R, Herndon D. High frequency percus- sive ventilation in pediatric patients with inhalation inju- ry. J Burn Care Rehabil 1999; 20(3): 232-5. [Crossref]  [PubMed]
48. Dai NT, Chen TM, Cheng TY, et al. The comparison of ear- ly fluid therapy in extensive flame burns between inhalation and noninhalation injuries. Burns 1998; 24(7): 671-5. [Crossref]  [PubMed]
49. Tanaka H, Wada T, Simazaki S, Hanumadass M, Reyes HM, Matsuda T. Effects of cimetidine on fluid requirement during resuscitation of third-degree burns. J Burn Care Re- habil 1991; 12(5): 425-9. [Crossref]  [PubMed]
50. Matsuda T, Tanaka H, Williams S, Hanumadass M, Ab- carian H, Reyes H. Reduced fluid volume requirement for resuscitation of third-degree burns with high-dose vitamin C. J Burn Care Rehabil 1991; 12(6): 525-32. [Crossref]  [PubMed]
51. Luo G, Peng Y, Yuan Z, et al. Inhalation injury in southwest China--the evolution of care. Burns 2010; 36(4): 506-10. [Crossref]  [PubMed]
52. Demir S, Erturk A, Gunal YD, et al. Contribution of Bone Marrow-Derived Mesenchymal Stem Cells to Healing of Pulmonary Contusion-Created Rats. J Surg Res 2021; 261: 205-14. [Crossref]  [PubMed]
53. Reagan MR, Kaplan DL. Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 2011; 29(6): 920-7. [Crossref]  [PubMed]  [PMC]
54. Matthay MA, Thompson BT, Read EJ, et al. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 2010; 138(4): 965-72. [Crossref]  [PubMed]  [PMC]
55. Cui P, Xin H, Yao Y, et al. Human amnion-derived mesen- chymal stem cells alleviate lung injury induced by white smoke inhalation in rats. Stem Cell Res Ther 2018; 9(1): 101. [Crossref]  [PubMed]  [PMC]
56. Ihara K, Fukuda S, Enkhtaivan B, et al. Adipose-derived stem cells attenuate pulmonary microvascular hyperper- meability after smoke inhalation. PLoS One 2017; 12(10): e0185937. [Crossref]  [PubMed]  [PMC]
57. Song M, Lv Q, Zhang X, et al. Dynamic Tracking Human Mesenchymal Stem Cells Tropism following Smoke Inhala- tion Injury in NOD/SCID Mice. Stem Cells Int 2016; 2016: 1691856. [Crossref]  [PubMed]  [PMC]
58. Chen W, Zhu F, Guo GH, Zhan JH. [Effect of bone marrow mesenchymal stem cells engraftment on secretion of inflam- matory cytokine in the early stages of smoke inhalation inju- ry in rabbits]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2011; 23(1): 21-3. [PubMed]
59. Zhu F, Guo GH, Chen W, Peng Y, Xing JJ, Wang NY. [Effect of bone marrow-derived mesenchymal stem cells transplan- tation on the inflammatory response and lung injury in rabbit with inhalation injury]. Zhonghua Shao Shang Za Zhi 2010; 26(5): 360-5. [PubMed]
60. Fontan JJ, Cortright DN, Krause JE, et al. Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat. Am J Physiol Lung Cell Mol Physiol 2000; 278(2): L344-55. [Crossref]  [PubMed]
61. Lange M, Enkhbaatar P, Traber DL, et al. Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inha- lation injury. J Appl Physiol (1985) 2009; 107(1): 176-84. [Crossref]  [PubMed]  [PMC]
62. Esechie A, Kiss L, Olah G, et al. Protective effect of hydro- gen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) 2008; 115(3): 91-7. [Crossref]  [PubMed]
63. Esechie A, Enkhbaatar P, Traber DL, et al. Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury. Br J Pharmacol 2009; 158(6): 1442-53. [Crossref]  [PubMed]  [PMC]
64. Han ZH, Jiang YI, Duan YY, Wang XY, Huang Y, Fang TZ. Protective effects of hydrogen sulfide inhalation on oxidative stress in rats with cotton smoke inhalation-induced lung injury. Exp Ther Med 2015; 10(1): 164-8. [Crossref]  [PubMed]  [PMC]
65. Wood EJ. Marks' basic medical biochemistry: A clinical ap- proach (second edition). Biochem Mol Biol Educ 2006; 34(5):395. [Crossref]  [PubMed]
66. Jiao XY, Gao E, Yuan Y, et al. INO-4885 [5,10,15,20-tetra[N-(benzyl-4'-carboxylate)-2-pyridini- um]-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice. J Pharmacol Exp Ther 2009; 328(3): 777-84. [Crossref]  [PubMed]  [PMC]
67. Hamahata A, Enkhbaatar P, Lange M, et al. Administration of a peroxynitrite decomposition catalyst into the bronchial artery attenuates pulmonary dysfunction after smoke inha- lation and burn injury in sheep. Shock 2012; 38(5): 543-8. [Crossref]  [PubMed]
68. Ito H, Malgerud E, Asmussen S, Lopez E, Salzman AL, Enkhbaatar P. R-100 improves pulmonary function and systemic fluid balance in sheep with combined smoke-inha- lation injury and Pseudomonas aeruginosa sepsis. J Transl Med 2017; 15(1): 266. [Crossref]  [PubMed]  [PMC]
69. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005; 4(5): 421-40. [Crossref]  [PubMed]
70. Peralta-Leal A, Rodriguez-Vargas JM, Aguilar-Quesada R, et al. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radic Biol Med 2009; 47(1): 13-26. [Crossref]  [PubMed]
71. Bartha E, Asmussen S, Olah G, et al. Burn and smoke injury activates poly(ADP-ribose)polymerase in circulating leu- kocytes. Shock 2011; 36(2): 144-8. [Crossref]  [PubMed]  [PMC]
72. Avlan D, Taskinlar H, Unlu A, et al. The role of poly(ADP-ri- bose) synthetase inhibition on the intestinal mucosal barrier after thermal injury. Burns 2004; 30(8): 785-92. [Crossref]  [PubMed]
73. Shimoda K, Murakami K, Enkhbaatar P, et al. Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 2003; 285(1): L240-9. [Crossref]  [PubMed]
74. Nelson C, Lee J, Ko K, et al. Therapeutic Efficacy of Es- omeprazole in Cotton Smoke-Induced Lung Injury Mod- el. Front Pharmacol 2017; 8: 16. [Crossref]  [PubMed]  [PMC]
75. Ding H, Lv Q, Wu S, et al. Intratracheal Instillation of Perflu- orohexane Modulates the Pulmonary Immune Microenviron- ment by Attenuating Early Inflammatory Factors in Patients With Smoke Inhalation Injury: A Randomized Controlled Clinical Trial. J Burn Care Res 2017; 38(4): 251-9. [Crossref]  [PubMed]
76. Sun Y, Qiu X, Wu G, et al. The effects of porcine pulmo- nary surfactant on smoke inhalation injury. J Surg Res 2015; 198(1): 200-7. [Crossref]  [PubMed]
77. Rose JJ, Wang L, Xu Q, et al. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Ther- apy. Am J Respir Crit Care Med 2017; 195(5): 596-606. [Crossref]  [PubMed]  [PMC]
78. Nelson L. Acute cyanide toxicity: mechanisms and manifes- tations. J Emerg Nurs 2006; 32(4 Suppl): S8-11. [Crossref]  [PubMed]
79. Suman SG, Gretarsdottir JM. Chemical and Clini- cal Aspects of Metal-Containing Antidotes for Poison- ing by Cyanide. Met Ions Life Sci 2019; 19. [Crossref]  [PubMed]
80. Hall JE, Hall ME. Guyton and Hall textbook of medical phys- iology. 14th edition. ed. Philadelphia, PA: Elsevier; 2021. Chapter 41. [Link]
81. Blumenthal I. Carbon monoxide poisoning. J R Soc Med 2001;94(6): 270-2. [Crossref]  [PubMed]  [PMC]
82. Sips PY, Shi X, Musso G, et al. Identification of specific met- abolic pathways as druggable targets regulating the sensitivity to cyanide poisoning. PLoS One 2018; 13(6): e0193889. [Crossref]  [PubMed]  [PMC]
83. Borron SW, Baud FJ. Antidotes for acute cyanide poisoning. Curr Pharm Biotechnol 2012; 13(10): 1940-8. [Crossref]  [PubMed]
84. Datta PK, Roy Chowdhury S, Aravindan A, Saha S, Rapaka S. Medical and Surgical Care of Critical Burn Patients: A Comprehensive Review of Current Evidence and Practice. Cureus 2022; 14(11): e31550. [Crossref]
85. Moore SJ, Norris JC, Walsh DA, Hume AS. Antidotal use of methemoglobin forming cyanide antagonists in concur- rent carbon monoxide/cyanide intoxication. J Pharmacol Exp Ther 1987; 242(1): 70-3. [PubMed]
86. Pamidi PV, DeAbreu M, Kim D, Mansouri S. Hydroxocobal- amin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta 2009; 401(1-2): 63-7. [Crossref]  [PubMed]
87. Meillier A, Heller C. Acute Cyanide Poisoning: Hydroxoco- balamin and Sodium Thiosulfate Treatments with Two Out- comes following One Exposure Event. Case Rep Med 2015; 2015: 217951. [Crossref]  [PubMed]  [PMC]